| Company Name | GEXVal Inc. |
| Mailing Address | 12-09 Shonan iPark 2-26-1 Muraoka Higashi, Fujisawa-shi, Kanagawa, 251-8555, Japan |
| Establishment | 1st February, 2018 |
| Capital | JPY 45,000,000 (as of May 2024) |
| Representative | Juran Kato |
| Board/Employee | 9 (as of May 2024) |
| Business | Research and development of drugs targeting rare and untreatable diseases |
| Major Shareholders | Mitsubishi UFJ Capital Co Ltd eBEST INVESTMENT & SECURITIES Co Ltd YK VENTURE PARTNERS Co Ltd Axil Capital Advisors KK Hana Securities Co Ltd Healthcare Innovation Co Ltd Takeda Pharmaceutical Co Ltd TNP Threads Of Light Corporation UTC Investment Co Ltd Juran Kato |
| Subsidiary | GEXVal AU Pty Ltd L 2 169 Pirie St, Adelaide, SA 5000, Australia |
